Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone Plus Ketamine for Major Depressive Disorder and Alcohol Use Disorder
NCT03658330Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- May 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ketamine, naltrexone in major depressive disorder (MDD), alcohol use disorder (AUD), sponsored by United States Department of Veterans Affairs. Started May 2016; status: completed.
02
Drugs
ketaminenaltrexone
03
Conditions
major depressive disorder (MDD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03658330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658330.